Chengzhi Lu

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial

Jie Wang, Yuehui Yin, Chengzhi Lu et al. · EClinicalMedicine · 2024 · 24 citations · Full text

Medicine, Cardiology, Nephrology +16

Preventive Effects of Nicorandil Against Contrast-Induced Nephropathy in Patients With Moderate Renal Insufficiency Undergoing Percutaneous Coronary Intervention

Peng Zhāng, Wenyuan Li, Shicheng Yang et al. · Angiology · 2019 · 23 citations

Medicine, Cardiology, Pharmacology +15

The relationship between serum uric acid and cognitive function in patients with chronic heart failure

Weihua Niu, Huifeng Yang, Chengzhi Lu · BMC Cardiovascular Disorders · 2020 · 17 citations · Full text

Medicine, Cardiology, Functional Decline +11

The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle‐aged and elderly population: A nationwide prospective cohort study

Qiang He, Rujie Zheng, Wenjuan Song et al. · Diabetes Obesity and Metabolism · 2024 · 16 citations · Full text

Education, Geriatric Medicine, Aging +16